000 04259nam a22004335c 4500
999 _c7097
_d7097
001 7097
003 ES-MaUEC
005 20200706095938.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 190107s2019 si a s |||| 0|eng d
020 _a9789811329319
024 7 _a10.1007/978-981-13-2931-9
_2doi
040 _bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC280
_b.P74 2019EB
245 0 0 _aPremalignant Conditions of the Oral Cavity
_cedited by Peter A. Brennan, Tom Aldridge, Raghav C. Dwivedi.
264 1 _aSingapore
_bSpringer Singapore :
_bImprint: Springer
_c2019.
300 _aXIV, 276 páginas 51 ilustraciones, 48 ilustraciones a color
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 1 _aHead and Neck Cancer Clinics,
_x2364-4060
490 0 _aMedicine (Springer-11650)
505 0 _aIntroduction to oral premalignant lesions including epidemiology -- Development, relevant anatomy and physiology of the oral cavity and mucosa -- Basic cellular and molecular biology to include the effects of carcinogens (smoking, alcohol, betel nut, HPV, chronic candida) -- Pathophysiology of the transformation from normal mucosa to invasive malignancy (carcinogenesis) including dysplasia -- Leukoplakia including benign lesions -- Erythroplakia and erythroleukoplakia.-The lichenoid group of diseases including erosive and atrophic lichen planus.-Systemic diseases that are potentially pre-cancerous (iron deficiency anaemic, immunosuppression -- Clinical presentation of oral mucosal premalignant lesions (this will be a larger section), and include high and low risk lesions -- Diagnosis including biopsy techniques and other relevant investigations -- Management of premalignant disease of the oral mucosa with up to date clinical trials and adjuvant therapies. Role of surgery, laser treatments -- The future. .
520 3 _aOral squamous cell carcinoma (SCC) is the 13th commonest cancer worldwide, and the most common cancer in the Asian subcontinent due to the widespread habit of tobacco and betel nut chewing. Despite many advances in diagnosis and treatment, the survival statistics have only marginally improved. However our understanding of the disease process and transformation from pre-cancerous lesions of the oral mucosa to an invasive SCC cancer and their progression has expanded exponentially. There are many conditions of the oral mucosa that can progress to an invasive malignancy. A thorough understanding of these conditions is a prerequisite for all those involved in the management of the diseases of the oral mucosa and head and neck region. The recognition and timely treatment of potentially pre-malignant conditions of the oral cavity can minimize the change to an overt malignancy in many patients through patient education, appropriate treatment and surveillance. In this book we cover relevant anatomy, biology, diagnosis and latest management strategies for pre-cancerous conditions that affect the oral mucosa. The respective chapters are written by expert contributors from around the world, lending the book a global perspective and making it an essential guide for all those involved in the management of pre-malignant lesions arising in this challenging anatomical region.
650 1 4 _aOncology.
_0http://scigraph.springernature.com/things/product-market-codes/H33160
653 0 _aOncology  .
700 1 _aBrennan, Peter A.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aAldridge, Tom.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aDwivedi, Raghav C.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106937
776 0 8 _iPrinted edition:
_z9789811329302
776 0 8 _iPrinted edition:
_z9789811329326
830 0 _aHead and Neck Cancer Clinics,
_x2364-4060
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-2931-9
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_el